EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment

Joon-Tae Kim iD, Ji Sung Lee iD, Hyunsoo Kim iD, Beom Joon Kim iD, Jihoon Kang iD, Keon-Joo Lee iD, Jong-Moo Park iD, Kyusik Kang iD, Soo Joo Lee iD, Jae Guk Kim iD, Jae-Kwan Cha iD, Dae-Hyun Kim iD und 24 weitere

Journal of the American Heart Association · 04.02.2025 · 14 (3)

DOI: 10.1161/jaha.124.038080 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.02.2025. Verfasst von Joon-Tae Kim und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Chonnam National University Hospital, Chonnam National University Medical School Gwangju Korea. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Atorvastatin, Ischemic Stroke, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Research specifically addressing the efficacy of rosuvastatin versus atorvastatin in patients with ischemic stroke is insufficient. Using a large stroke registry, we investigated whether 2 commonly used statins, rosuvastatin and atorvastatin, differ in their effectiveness in reducing the risk of vascular events in patients with acute ischemic stroke.

Methods

We analyzed data from a nationwide stroke registry in South Korea between January 2011 and April 2022. Patients with acute ischemic stroke within 7 days of onset who were prescribed either atorvastatin or rosuvastatin at discharge were included. The primary outcome was a composite of recurrent stroke (either hemorrhagic or ischemic), myocardial infarction, and all‐cause mortality within 1 year.

Results

A total of 43 512 patients (age, 69.2±12.5 years; male, 59.8%) were analyzed in this study. Atorvastatin was used in 84.8% (n=36 903), and rosuvastatin was used in 15.2% (n=6609). The 1‐year cumulative event rate of the composite of recurrent stroke, myocardial infarction, and all‐cause mortality was significantly lower in the rosuvastatin group than in the atorvastatin group (9.7% [95% CI, 9.0–10.5] versus 10.7% [95% CI, 10.4–11.0]; P =0.049). Cox proportional hazards analysis revealed that rosuvastatin, compared with atorvastatin, was significantly associated with less risk of 1‐year composite of recurrent stroke, myocardial infarction, and all‐cause mortality, with an absolute risk reduction of 1% [95% CI, −1.8 to −0.2] and a relative risk reduction of 11% (hazard ratio, 0.89 [95% CI, 0.82–0.97]). However, there were discrepancies in the statistical significance of the results between the propensity score matching and stabilized inverse probability of treatment weighting analysis.

Conclusions

The results of this analysis of a large cohort of patients with ischemic stroke suggested that, compared with atorvastatin, rosuvastatin was significantly associated with a reduced risk of a 1‐year composite of recurrent stroke, myocardial infarction, and all‐cause mortality in patients with acute ischemic stroke. However, in real clinical practice, rosuvastatin is used less than one‐fifth as frequently as atorvastatin in patients with acute ischemic stroke. This study serves as a hypothesis‐generating function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rosuvastatin CalciumAtorvastatinIschemic StrokeHydroxymethylglutaryl-CoA Reductase InhibitorsHumansMaleFemaleAgedRepublic of KoreaRegistriesMiddle AgedTreatment OutcomeRecurrenceMyocardial InfarctionRetrospective Studies

Stichwörter der Autor:innen

acute isc hemic strokeatorvastatinrosuvastatin

Substanzen

Rosuvastatin CalciumAtorvastatinHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology Chonnam National University Hospital, Chonnam National University Medical School Gwangju Korea.
  • Clinical Research Center Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine Seoul Korea.
  • Department of Neurology Seoul National University College of Medicine, Seoul National University Bundang Hospital Seongnam Korea.
  • Department of Neurology Korea University Guro Hospital Seoul Korea.
  • Department of Neurology Uijeongbu Eulji Medical Center, Eulji University School of Medicine Uijeongbu-si Korea.
  • Department of Neurology Nowon Eulji Medical Center, Eulji University School of Medicine Seoul Korea.

ORCID-Profile: Joon-Tae Kim, Ji Sung Lee, Hyunsoo Kim, Beom Joon Kim, Jihoon Kang, Keon-Joo Lee, Jong-Moo Park, Kyusik Kang, Soo Joo Lee, Jae Guk Kim, Jae-Kwan Cha, Dae-Hyun Kim, Tai Hwan Park, Kyungbok Lee, Jun Lee, Keun-Sik Hong, Yong-Jin Cho, Hong-Kyun Park, Byung-Chul Lee, Kyung-Ho Yu, Mi Sun Oh, Jay Chol Choi, Jee-Hyun Kwon, Wook-Joo Kim, Dong-Ick Shin, Kyu Sun Yum, Sung Il Sohn, Jeong-Ho Hong, Man-Seok Park, Wi-Sun Ryu, Kwang-Yeol Park, Juneyoung Lee, Jeffrey L Saver, Hee-Joon Bae

Zitieren

APA

Kim, J. T., Lee, J. S., Kim, H., Kim, B. J., Kang, J., Lee, K. J., Park, J. M., Kang, K., Lee, S. J., Kim, J. G., Cha, J. K., Kim, D. H., Park, T. H., Lee, K., Lee, J., Hong, K. S., Cho, Y. J., Park, H. K., Lee, B. C., …, & Bae, H. J. (2025). Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment. Journal of the American Heart Association, 14(3). https://doi.org/10.1161/jaha.124.038080

Vancouver

Kim JT, Lee JS, Kim H, Kim BJ, Kang J, Lee KJ, et al. Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment. Journal of the American Heart Association. 2025;14(3). doi:10.1161/jaha.124.038080

BibTeX
@article{Kim2025,
  author = {Kim, Joon-Tae and Lee, Ji Sung and Kim, Hyunsoo and Kim, Beom Joon and Kang, Jihoon and Lee, Keon-Joo and Park, Jong-Moo and Kang, Kyusik and Lee, Soo Joo and Kim, Jae Guk and Cha, Jae-Kwan and Kim, Dae-Hyun and Park, Tai Hwan and Lee, Kyungbok and Lee, Jun and Hong, Keun-Sik and Cho, Yong-Jin and Park, Hong-Kyun and Lee, Byung-Chul and Yu, Kyung-Ho and Oh, Mi Sun and Kim, Dong-Eog and Choi, Jay Chol and Kwon, Jee-Hyun and Kim, Wook-Joo and Shin, Dong-Ick and Yum, Kyu Sun and Sohn, Sung Il and Hong, Jeong-Ho and Lee, Sang-Hwa and Park, Man-Seok and Ryu, Wi-Sun and Park, Kwang-Yeol and Lee, Juneyoung and Saver, Jeffrey L and Bae, Hee-Joon},
  title = {Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {3},
  doi = {10.1161/jaha.124.038080}
}
Kostenlos starten →